• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞免疫球蛋白样受体B4对单核细胞激活的双相正负调节取决于其免疫酪氨酸抑制基序中酪氨酸残基的位置。

A dual positive and negative regulation of monocyte activation by leukocyte Ig-like receptor B4 depends on the position of the tyrosine residues in its ITIMs.

作者信息

Park Mijeong, Liu Robert W, An Hongyan, Geczy Carolyn L, Thomas Paul S, Tedla Nicodemus

机构信息

1 Mechanisms of Diseases Translational Research, University of New South Wales, School of Medical Sciences, Department of Pathology, Sydney, Australia.

2 Stanford University School of Medicine, Department of Medicine, Stanford, CA, USA.

出版信息

Innate Immun. 2017 May;23(4):381-391. doi: 10.1177/1753425917699465. Epub 2017 Mar 16.

DOI:10.1177/1753425917699465
PMID:28409541
Abstract

The leukocyte Ig-like receptor B4 (LILRB4) is an inhibitory cell surface receptor, primarily expressed on mono-myeloid cells. It contains 2 C-type Ig-like extracellular domains and a long cytoplasmic domain that contains three intracellular immunoreceptor tyrosine-based inhibitory motifs (ITIMs). Data suggest that LILRB4 suppresses Fc receptor-dependent monocyte functions via its ITIMs, but relative contributions of the three ITIMs are not characterised. To address this, tyrosine (Tyr) residues at positions 337, 389 and 419 were single, double or triple mutated to phenylalanine and stably transfected into a human monocytic cell line, THP-1. Intact Tyr was sufficient to maximally inhibit FcγRI-mediated TNF-α production in THP-1 cells, but, paradoxically, Tyr significantly enhanced TNF-α production. In contrast, bactericidal activity was significantly enhanced in mutants containing Tyr, while Tyr markedly inhibited bacteria killing. Taken together, these results indicate that LILRB4 might have dual inhibitory and activating functions, depending on the position of the functional tyrosine residues in its ITIMs and/or the nature of the stimuli.

摘要

白细胞免疫球蛋白样受体B4(LILRB4)是一种抑制性细胞表面受体,主要表达于单核-髓系细胞。它包含2个C型免疫球蛋白样细胞外结构域和一个长的细胞质结构域,该细胞质结构域包含三个基于免疫受体酪氨酸的细胞内抑制基序(ITIM)。数据表明,LILRB4通过其ITIM抑制Fc受体依赖性单核细胞功能,但三个ITIM的相对作用尚未明确。为了解决这个问题,将第337、389和419位的酪氨酸(Tyr)残基分别单突变、双突变或三突变为苯丙氨酸,并稳定转染到人单核细胞系THP-1中。完整的Tyr足以最大程度地抑制THP-1细胞中FcγRI介导的TNF-α产生,但矛盾的是,Tyr显著增强了TNF-α的产生。相反,含有Tyr的突变体的杀菌活性显著增强,而Tyr显著抑制细菌杀伤。综上所述,这些结果表明,LILRB4可能具有双重抑制和激活功能,这取决于其ITIM中功能性酪氨酸残基的位置和/或刺激的性质。

相似文献

1
A dual positive and negative regulation of monocyte activation by leukocyte Ig-like receptor B4 depends on the position of the tyrosine residues in its ITIMs.白细胞免疫球蛋白样受体B4对单核细胞激活的双相正负调节取决于其免疫酪氨酸抑制基序中酪氨酸残基的位置。
Innate Immun. 2017 May;23(4):381-391. doi: 10.1177/1753425917699465. Epub 2017 Mar 16.
2
Leukocyte Ig-like receptor B4 (LILRB4) is a potent inhibitor of FcgammaRI-mediated monocyte activation via dephosphorylation of multiple kinases.白细胞免疫球蛋白样受体 B4(LILRB4)通过去磷酸化多种激酶,抑制 FcγRI 介导的单核细胞激活。
J Biol Chem. 2009 Dec 11;284(50):34839-48. doi: 10.1074/jbc.M109.035683. Epub 2009 Oct 15.
3
Leukocyte immunoglobulin-like receptor B4 regulates key signalling molecules involved in FcγRI-mediated clathrin-dependent endocytosis and phagocytosis.白细胞免疫球蛋白样受体B4调节参与FcγRI介导的网格蛋白依赖性内吞作用和吞噬作用的关键信号分子。
Sci Rep. 2016 Oct 11;6:35085. doi: 10.1038/srep35085.
4
LILRB4 ITIMs mediate the T cell suppression and infiltration of acute myeloid leukemia cells.LILRB4 ITIMs 介导 T 细胞抑制和急性髓系白血病细胞浸润。
Cell Mol Immunol. 2020 Mar;17(3):272-282. doi: 10.1038/s41423-019-0321-2. Epub 2019 Nov 7.
5
Inhibition of pathologic inflammation by leukocyte Ig-like receptor B4 and related inhibitory receptors.白细胞免疫球蛋白样受体B4及相关抑制性受体对病理性炎症的抑制作用
Immunol Rev. 2007 Jun;217:222-30. doi: 10.1111/j.1600-065X.2007.00522.x.
6
The inhibitory potential of Fc receptor homolog 4 on memory B cells.Fc受体同源物4对记忆B细胞的抑制潜能
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13489-94. doi: 10.1073/pnas.1935944100. Epub 2003 Nov 3.
7
Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.杀伤细胞抑制性受体抑制细胞活化过程中基于免疫受体酪氨酸的抑制基序N端和C端的不同作用
J Immunol. 1999 Mar 15;162(6):3168-75.
8
Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling.关于免疫受体酪氨酸抑制基序(ITIMs)、免疫受体酪氨酸激活基序(ITAMs)以及免疫受体酪氨酸激活基序类似物(ITAMis):重新审视免疫球蛋白Fc受体信号传导
Immunol Rev. 2015 Nov;268(1):66-73. doi: 10.1111/imr.12336.
9
Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor.一类新型人类免疫球蛋白超家族成员的分子鉴定,该家族成员具有基于免疫受体酪氨酸的抑制基序,且与小鼠gp49B1抑制性受体具有同源性。
J Immunol. 1997 Sep 1;159(5):2342-9.
10
PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.程序性死亡受体1(PD-1)免疫受体通过招募含src同源2结构域的酪氨酸磷酸酶2至磷酸酪氨酸来抑制B细胞受体介导的信号传导。
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13866-71. doi: 10.1073/pnas.231486598. Epub 2001 Nov 6.

引用本文的文献

1
Leukocyte immunoglobulin-like receptor B4: A keystone in immune modulation and therapeutic target in cancer and beyond.白细胞免疫球蛋白样受体B4:免疫调节的关键因子及癌症等疾病的治疗靶点
Cancer Innov. 2024 Oct 22;3(6):e153. doi: 10.1002/cai2.153. eCollection 2024 Dec.
2
Leukocyte immunoglobulin-like receptor B4 (LILRB4) in acute myeloid leukemia: From prognostic biomarker to immunotherapeutic target.急性髓系白血病中的白细胞免疫球蛋白样受体B4(LILRB4):从预后生物标志物到免疫治疗靶点
Chin Med J (Engl). 2024 Nov 20;137(22):2697-2711. doi: 10.1097/CM9.0000000000003195. Epub 2024 Jul 8.
3
LILRB4 Checkpoint for Immunotherapy: Structure, Mechanism and Disease Targets.
LILRB4 免疫疗法检查点:结构、机制和疾病靶点。
Biomolecules. 2024 Feb 4;14(2):187. doi: 10.3390/biom14020187.
4
An Update on the Effects of Vitamin D on the Immune System and Autoimmune Diseases.维生素 D 对免疫系统和自身免疫性疾病影响的最新研究进展。
Int J Mol Sci. 2022 Aug 29;23(17):9784. doi: 10.3390/ijms23179784.
5
NK cells require immune checkpoint receptor LILRB4/gp49B to control neurotropic Zika virus infections in mice.自然杀伤细胞需要免疫检查点受体 LILRB4/gp49B 来控制小鼠的神经嗜性寨卡病毒感染。
JCI Insight. 2022 Feb 8;7(3):e151420. doi: 10.1172/jci.insight.151420.
6
Characterization of the Leucocyte Immunoglobulin-like Receptor B4 () Expression in Microglia.小胶质细胞中白细胞免疫球蛋白样受体B4()表达的特征分析
Biology (Basel). 2021 Dec 9;10(12):1300. doi: 10.3390/biology10121300.
7
The Genomic Organization of the Region Remained Largely Conserved Throughout Primate Evolution: Implications for Health And Disease.区域的基因组组织在灵长类动物进化过程中基本保持保守:对健康和疾病的影响。
Front Immunol. 2021 Oct 19;12:716289. doi: 10.3389/fimmu.2021.716289. eCollection 2021.
8
Leukocyte Immunoglobulin-Like Receptors in Regulating the Immune Response in Infectious Diseases: A Window of Opportunity to Pathogen Persistence and a Sound Target in Therapeutics.白细胞免疫球蛋白样受体在调节传染病中的免疫反应:病原体持续存在的机会窗口和治疗的良好靶点。
Front Immunol. 2021 Sep 14;12:717998. doi: 10.3389/fimmu.2021.717998. eCollection 2021.
9
Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer.白细胞免疫球蛋白样受体B亚家族:癌症中的治疗靶点
Antib Ther. 2021 Feb 9;4(1):16-33. doi: 10.1093/abt/tbab002. eCollection 2021 Jan.
10
LILRB4, from the immune system to the disease target.白细胞免疫球蛋白样受体B4,从免疫系统到疾病靶点。
Am J Transl Res. 2020 Jul 15;12(7):3149-3166. eCollection 2020.